Real-Time, Risk-Based Clinical Trial Quality Management in China: Development of a Digital Monitoring Platform
In clinical practice, our tool would enable the automated monitoring and detection of risk points throughout all clinical trial stages; accurately identify the most relevant trial procedure and function line; and notify quality management personnel, in real time, to take prompt actions and dynamically prevent the recurrence of quality issues.
Authors
- Yannan Yuan (ORCID: https://orcid.org/0000-0001-9249-7576)
- Min Jiang (ORCID: https://orcid.org/0000-0003-2706-8526)
- Ying Gong
- J Y Chen
- Yuan Sheng (ORCID: https://orcid.org/0000-0001-8099-9659)
- Zhiying Fu (ORCID: https://orcid.org/0000-0002-2152-0828)
- Jie Ai
- Yun Mei
- Shuhua Zhao (ORCID: https://orcid.org/0009-0002-4939-6299)
Institutions
- Peking University (CN)
- Peking University Cancer Hospital (CN)
- Ministry of Education (ET)
- Pfizer (China) (CN)
- Baidu (China) (CN)
Publication Details
- Journal
- JMIR Medical Informatics
- Published
- 2025-04-25
- DOI
- https://doi.org/10.2196/64114
- Primary Topic
- Meta-analysis and systematic reviews
- Type
- article
- Field-Weighted Citation Impact
- 0.00